Antiviral supplement formulations
US11826377B2 · kind B2 · utility
0Cited by
15References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 17, 2021 |
| Grant date | Nov 28, 2023 |
| Priority date | — |
| Expiry date | Nov 17, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure provides an oral antiviral supplement composition comprising a lysine, an ascorbic compound, a flavonoid glycoside, a threonine, and a pyridoxine. The disclosure also provides a method of reducing viral replication in a cell comprising treating a virus-infected cell with a composition of the disclosure. The disclosure further provides a method for the treatment and prophylaxis of a viral infection in a patient comprising administering a composition of the disclosure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.